AI, Precision Medicine & Women’s Health in Focus
By Helena Strigård, Founder Ventures Accelerated
Sept 15, 2025
Excerpt from Cell & Gene Therapy Insights, article by Helena Strigård
Cell & Gene Therapy Insights recently published an article by Helena Strigård, Founder of Ventures Accelerated, exploring the untapped medical and market potential in women’s health and the transformative role of AI and precision medicine.
The piece moves beyond the traditional framing of women’s health as fertility, menopause, or gynaecological conditions. Instead, it highlights how major diseases such as heart disease and diabetes manifest differently in women. These differences, often overlooked in clinical practice and research design, have contributed to misdiagnosis, delayed treatment, and worse outcomes for women worldwide.
Helena argues that the convergence of AI, cell and gene therapy, and precision medicine is set to transform this landscape. By analysing vast and diverse datasets, from genetic profiles to wearable device data, AI can reveal gender-specific disease patterns, support earlier interventions, and lead to better treatment strategies. This opens the door to correcting systemic blind spots that have persisted for decades.
Drawing on her “Venture Road California” tour, a two-week journey through California’s life science ecosystem, Helena reflects on the global potential of this transformation. As she notes, “the intersection of precision medicine, AI, and women’s health presents a sweet spot for both Californian and Nordic ecosystems.” This observation not only encapsulates the theme of the article but also underscores the value of linking innovation hubs across geographies where diverse expertise, cross-sector convergence, and openness to new ideas can create fertile ground for breakthroughs in women’s health.
The article also features expert perspectives that illustrate the urgency of acting now. Dr. Karin Rosén, Board Member of Diamyd Medical, points out that women with Type 1 diabetes face nearly ten times higher cardiovascular risk than men, making AI-driven precision medicine an essential tool for identifying high-risk individuals earlier and preventing organ damage. Meanwhile, Nina Rawal, Partner at Trill Impact Venture, frames women’s health as not just a clinical issue but an economic one, arguing that closing the women’s health gap could add up to US$1 trillion annually to the global economy by 2040.
Read the full article in Cell & Gene Therapy Insights
About Cell & Gene Therapy Insights
Cell & Gene Therapy Insights is a freely accessible, peer-reviewed journal focused on the fast-moving field of advanced therapies. Read worldwide by experts in academia, biotech, pharma and healthcare, it publishes expert opinions, original research and practical analysis on everything from science and clinical practice to regulation, manufacturing and commercialization. With its broad scope and open-access format, the journal serves as a key hub for sharing knowledge and connecting the people shaping the future of healthcare innovation.
Visit the Cell & Gene Therapy Insights journal page to explore more articles and insights on the future of advanced therapies.